Therapeutics and Clinical Risk Management, 2019 Chin-Chou Huang,1–5 Min-Ji Charng2,3 1Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; 2Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; 3Faculty of Medicine, School
Huang CC, Charng MJ
doaj
Clinical Anatomy, EarlyView.ABSTRACT Anatomical descriptions of left‐sided oblique coronary branches remain inconsistent, hindering imaging interpretation and surgical planning. To quantify the prevalence, branching patterns and morphometry of the ramus intermedius (RI) and diagonal branches, and propose a unified nomenclature.
Yuqian Dai +3 more
wiley +1 more source
CardioPulse ArticlesThe European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitorsLeaders in cardiovascular medicine of todayProfessor David Wood, Imperial College, LondonPrevention of global cardiovascular diseaseThe plunging mortality of cardiovascular disease in IsraelBook reviewEuropean Society of Cardiology textbook of preventive cardiology [PDF]
, 2016 E. Blind +5 more
openalex +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Coronary perforation is a feared complication of chronic total occlusion‐percutaneous coronary intervention (CTO‐PCI), especially in large vessel perforations, which often require implantation of covered stents (CS). However, the deployment of multiple CSs may not always be effective.
Gao Haokao +3 more
wiley +1 more source
Racial/Ethnic Differences in Cardiac Care: The Weight of the Evidence [PDF]
, 2002 A substantial and growing body of research indicates that race/ethnicity -- independent of clinical and socioeconomic factors -- continues to matter in the U.S. health care system.
core
The year in cardiovascular medicine 2021: interventional cardiology [PDF]
, 2021 Javier Escaned +3 more
openalex +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT We aimed to compare the long‐term efficacy and safety of drug‐coated balloon (DCB) and drug‐eluting stent (DES) following atherectomy for coronary arteries with severely calcified lesions. Of the 258 consecutive patients and 422 de novo lesions treated with DCB at Kanazawa Medical University Hospital, we retrospectively enrolled highly ...
Taka‐aki Takamura +11 more
wiley +1 more source
CardioPulse ArticlesLeaders in cardiovascular medicine todayPeter Libby MDRecent advances in cardiovascular magnetic resonance imagingHypertrophic cardiomyopathy score favoured at European Society of Cardiology Congress LondonPersonal experiences ofémigrécardiologists:Francesco Cosentino MD PhD FESCThe Korean Society of CardiologyTheKorean Circulation Journal [PDF]
, 2016 Jennifer L. Taylor
openalex +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Patients with hypertrophic obstructive cardiomyopathy (HOCM) were excluded from all major trials for transcatheter aortic valve replacement (TAVR). “Suicide left ventricle” occurring after TAVR is postulated to occur as a result of chronic pressure overload from fixed obstruction that is acutely relieved after the valve deployment ...
Muhammad Usman Almani +6 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Transcatheter aortic valve replacement (TAVR) has become a popular alternative to surgical aortic valve replacement (SAVR) for patients with valvular heart disease (VHD), particularly for those with aortic anomalies. Aims The study aimed to compare the risks of post‐TAVR complications between patients with bicuspid and tricuspid ...
Tingxi Zhu +8 more
wiley +1 more source